VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.

Nanomedicine-Nanotechnology Biology and Medicine is a leading journal published by Elsevier, dedicated to the exploration of innovative applications of nanotechnology in the fields of biology and medicine. With an ISSN of 1549-9634 and an E-ISSN of 1549-9642, this esteemed journal provides a platform for high-quality research, comprehensively covering areas including bioengineering, biomedical engineering, pharmaceutical science, and nanoscience. Notably, it holds a significant position in various categories with a Q2 ranking in multiple disciplines and a prestigious Q1 ranking in Pharmaceutical Science, emphasizing its impact within the scientific community. By facilitating access to cutting-edge studies and advancements, Nanomedicine-Nanotechnology Biology and Medicine serves as an essential resource for researchers, professionals, and students alike, contributing significantly to the ongoing development of nanomedicine and its pivotal role in improving healthcare outcomes. The journal operates without open access; however, it remains committed to disseminating valuable knowledge to a global audience.

Current Nanoscience is a prominent journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of nanoscience through the dissemination of high-quality research and review articles. Since its inception in 2006, the journal has provided a platform for innovative studies across a variety of related disciplines, including bioengineering, biomedical engineering, biotechnology, and nanotechnology, reflecting its diverse scope and interdisciplinary nature. With a Q3 ranking in several categories such as Biomedical Engineering and Pharmaceutical Science and a Scopus percentile ranking around the 60th in its field, Current Nanoscience serves as a vital resource for researchers and professionals seeking to stay abreast of the latest developments and breakthroughs. Although it operates without an open access model, the journal maintains a commitment to enhancing accessibility and relevance in the scientific community. The editorial team is focused on publishing articles that address both theoretical and practical aspects of nanoscience, ensuring that the findings contribute to knowledge and innovation in areas critical to technology and healthcare.

Nanotechnology Science and Applications, published by DOVE MEDICAL PRESS LTD, is a premier open-access journal dedicated to advancing knowledge in the fields of nanoscience and nanotechnology, particularly focusing on their applications in bioengineering, biomedical engineering, and pharmaceutical sciences. Since its inception in 2008, this journal has provided a platform for the dissemination of high-quality research that is rigorously peer-reviewed, ensuring that only the most impactful findings reach a global audience. With an impressive impact factor reflected in its recent categorization in the Q1 tier for Pharmaceutical Science and Q2 for Bioengineering and Nanoscience, it stands as a critical resource for researchers, practitioners, and students eager to explore the cutting-edge innovations within these rapidly evolving disciplines. The journal's commitment to accessibility and its robust indexing in Scopus—ranked highly in its respective categories—reinforces its importance as a leading forum for the exchange of scientific knowledge and the fostering of collaborative research in nanotechnology applications.

The Beilstein Journal of Nanotechnology is a prominent open access journal published by the Beilstein Institute that has been at the forefront of nanotechnology research since its inception in 2010. With a focus on cutting-edge developments in areas such as Electrical and Electronic Engineering, Materials Science, and Physics and Astronomy, this journal is ranked in the Q2 category across multiple scientific disciplines, reflecting its significant impact within the research community. The journal is accessible to a global audience and aims to foster innovation and application of nanotechnology across various fields. Featuring a rich convergence of interdisciplinary studies, the Beilstein Journal of Nanotechnology offers a platform for researchers to share their findings, thus advancing the frontiers of knowledge in this dynamic field. With publishers based in Frankfurt am Main, Germany, it continues to contribute to the scientific dialogue on nanoscience and its practical applications, making it an essential resource for academics, professionals, and students eager to stay at the cutting edge of technology.

Biomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.

DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.

International Journal of Nanomedicine, published by DOVE MEDICAL PRESS LTD, is a leading open access journal dedicated to advancing the field of nanomedicine and its applications in healthcare. Since its establishment in 2006, the journal has grown significantly, now encompassing a wide array of topics including bioengineering, biomaterials, biophysics, drug discovery, and pharmaceutical sciences, and is recognized in Q1 quartiles across major categories like *Nanoscience and Nanotechnology* and *Organic Chemistry*. The journal boasts an impressive standing within the Scopus rankings, with high percentiles across various related fields, making it an invaluable resource for researchers, professionals, and students seeking to stay informed on the latest innovations and developments in nanomedicine. With its commitment to fostering an accessible and collaborative academic environment, the International Journal of Nanomedicine serves as a vital platform for disseminating transformative research that impacts scientific practice and healthcare outcomes globally.

Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.